Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Surgery
Volume 2017 (2017), Article ID 2394365, 4 pages
https://doi.org/10.1155/2017/2394365
Case Report

An Unusual Case of Resistant Hypokalaemia in a Patient with Large Bowel Obstruction Secondary to Neuroendocrine Carcinoma of the Prostate

1Department of Hepatobiliary Surgery, Royal Free Hospital, Pond Street, London NW3 2QG, UK
2Department of Paediatrics, Eastbourne District General Hospital, Eastbourne BN21 2UD, UK
3Department of Transplantation, Leicester General Hospital, Leicester LE5 4PW, UK
4Department of General Surgery, St Helier Hospital, Carshalton SM5 1AA, UK

Correspondence should be addressed to Umasankar Mathuram Thiyagarajan; moc.liamg@noegrusamu

Received 29 July 2016; Revised 14 February 2017; Accepted 20 February 2017; Published 13 March 2017

Academic Editor: Makoto Ohori

Copyright © 2017 Umasankar Mathuram Thiyagarajan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. J. Evans, P. A. Humphrey, J. Belani, T. H. Van Der Kwast, and J. R. Srigley, “Large cell neuroendocrine carcinoma of prostate: a clinicopathologic summary of 7 cases of a rare manifestation of advanced prostate cancer,” American Journal of Surgical Pathology, vol. 30, no. 6, pp. 684–693, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. J. I. Epstein, M. B. Amin, H. Beltran et al., “Proposed morphologic classification of prostate cancer with neuroendocrine differentiation,” The American Journal of Surgical Pathology, vol. 38, no. 6, pp. 756–767, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. R. C. Graves and R. E. Millitzer, “Carcinoma of the prostate with metastases,” The Journal of Urology, vol. 33, pp. 235–251, 1935. View at Google Scholar
  4. C. J. Kickham, “Carcinoma of prostate simulating primary rectal malignancy,” The Journal of Urology, vol. 35, article 342, 1936. View at Google Scholar
  5. F. K. Arnheim, “Carcinoma of the prostate: a study of the postmortem findings in one hundred and seventy-six cases,” The Journal of Urology, vol. 50, pp. 599–603, 1948. View at Google Scholar
  6. L. M. Franks, “The spread of prostatic cancer,” The Journal of Pathology and Bacteriology, vol. 72, no. 2, pp. 603–611, 1956. View at Publisher · View at Google Scholar
  7. D. J. Bowrey, M. I. Otter, and P. J. Billings, “Rectal infiltration by prostatic adenocarcinoma: report on six patients and review of the literature,” Annals of the Royal College of Surgeons of England, vol. 85, no. 6, pp. 382–385, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Bonkhoff, “Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status,” Annals of Oncology, vol. 12, supplement 2, pp. S141–S144, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Bonkhoff, U. Stein, and K. Remberger, “Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate,” Virchows Archiv A Pathological Anatomy and Histopathology, vol. 423, no. 4, pp. 291–294, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. J. L. M. Krijnen, J. F. A. T. Bogdanowicz, C. A. Seldenrijk, P. G. H. Mulder, and T. H. Van Der Kwast, “The prognostic value of neuroendocrine differentiation in adenocarcinoma of the prostate in relation to progression of disease after endocrine therapy,” Journal of Urology, vol. 158, no. 1, pp. 171–174, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. J. R. Mackey, H.-J. Au, J. Hugh, and P. Venner, “Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival,” Journal of Urology, vol. 159, no. 5, pp. 1624–1629, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Chiaverotti, S. S. Couto, A. Donjacour et al., “Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer,” American Journal of Pathology, vol. 172, no. 1, pp. 236–246, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Mazzucchelli, D. Morichetti, A. Lopez-Beltran et al., “Neuroendocrine tumours of the urinary system and male genital organs: clinical significance,” BJU International, vol. 103, no. 11, pp. 1464–1470, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. V. S. Ghali and R. L. Garcia, “Prostatic adenocarcinoma with carcinoidal features producing adrenocorticotropic syndrome. Immunohistochemical study and review of the literature,” Cancer, vol. 54, no. 6, pp. 1043–1048, 1984. View at Publisher · View at Google Scholar · View at Scopus
  15. C. K. Meador, G. W. Liddle, D. P. Island et al., “Cause of Cushing's syndrome in patients with tumors arising from “nonendocrine” tissue,” The Journal of Clinical Endocrinology and Metabolism, vol. 22, pp. 693–703, 1962. View at Publisher · View at Google Scholar · View at Scopus
  16. M. F. Vuitch and G. Mendelsohn, “Relationship of ectopic ACTH production to tumor differentiation: a morphologic and immunohistochemical study of prostatic carcinoma with Cushing's syndrome,” Cancer, vol. 47, no. 2, pp. 296–299, 1981. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Nimalasena, A. Freeman, and S. Harland, “Paraneoplastic Cushing's syndrome in prostate cancer: a difficult management problem,” BJU International, vol. 101, no. 4, pp. 424–427, 2008. View at Publisher · View at Google Scholar · View at Scopus